| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $7.1M | -13.0% |
| Cost of Revenue | $5.2M | -8.1% |
| Gross Profit | $1.9M | -24.6% |
| R&D Expense | $55K | -1.8% |
| SG&A Expense | $10.8M | -45.5% |
| Operating Income | -$9.3M | +48.1% |
| Interest Expense | $838 | +256.6% |
| Pre-tax Income | -$10.2M | +43.8% |
| Income Tax | $81K |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.6M | +110.3% |
| Accounts Receivable | $1.1M | -17.0% |
| Inventory | $158K | -63.4% |
| Current Assets | $14.5M | +78.7% |
| Total Assets | $21.3M | +30.0% |
| Current Liabilities | $23.2M | +121.5% |
| Total Liabilities | $23.7M | +109.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.5M | +117.8% |
| Capital Expenditures | $30K | -86.3% |
| Investing Cash Flow | -$30K | +91.2% |
| Financing Cash Flow | $1.5M | +288.0% |
| Free Cash Flow | $2.4M | +117.3% |
| +218.1% |
| Net Income | -$10.2M | +43.6% |
| EPS (Basic) | -$3.45 | -447.6% |
| EPS (Diluted) | -$3.45 | -447.6% |
| Stockholders' Equity |
| -$2.1M |
| -140.3% |